找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: NeuroRadiosurgery: Case Review Atlas; Osama S. Abdelaziz,Antonio A.F. De Salles Book 2023 The Editor(s) (if applicable) and The Author(s),

[復(fù)制鏈接]
樓主: Iridescent
21#
發(fā)表于 2025-3-25 04:48:20 | 只看該作者
22#
發(fā)表于 2025-3-25 08:07:05 | 只看該作者
Medium Size Brain Arteriovenous Malformation (AVM) volume of 7.0?cc received a prescribed dose of 20.0 Gy normalized to 50% isodose line. At 12?months post-SRS, follow-up MRI showed a marked decrease in size of AVM nidus, coupled with perinidal high signal in T2 and FLAIR studies, denoting vasogenic edema. At 18?months post-SRS, follow-up MRI showe
23#
發(fā)表于 2025-3-25 14:46:46 | 只看該作者
24#
發(fā)表于 2025-3-25 18:25:11 | 只看該作者
25#
發(fā)表于 2025-3-25 22:26:25 | 只看該作者
Intraventricular Arteriovenous Malformation (AVM)ary); Linac-based SRS for right, lateral ventricle (body) AVM. The target volume of 3.6?cc received a marginal dose of 22.0 Gy normalized to 80% isodose line. At 24?months post-SRS, the patient reported complete resolution of his headaches. Serial post-SRS follow-up MRIs showed progressive reduction
26#
發(fā)表于 2025-3-26 01:14:14 | 只看該作者
Choroidal Fissure Arteriovenous Malformation (AVM) treated with adjunctive; Linac-based SRS for post-embolization residual, left, choroidal fissure AVM. The target volume of 2.4?cc received a marginal dose of 20.0 Gy normalized to 80% isodose line. The maximum dose to brain stem was 24.5 Gy. At 6?months post-SRS, the patient reported complete resol
27#
發(fā)表于 2025-3-26 05:10:48 | 只看該作者
Thalamic Arteriovenous Malformation (AVM)previous temporary, hemorrhage-associated manifestations (headache, right hemiparesis, and hemi-hypoesthesia). He was treated with upfront (primary); Linac-based SRS for left thalamic AVM. The target volume of 3.0?cc received a marginal dose of 18.0 Gy normalized to 80% isodose line. The maximum dos
28#
發(fā)表于 2025-3-26 09:19:22 | 只看該作者
Basal Ganglia Arteriovenous Malformation (AVM)ery from coma induced by last hemorrhage. He was treated with upfront (primary); Linac-based SRS for right basal ganglia (lentiform nucleus) AVM. The target volume of 3.2?cc received a marginal dose of 18.0 Gy normalized to 80% isodose line, in a 2-isocenter plan. Serial post-SRS follow-up MRIs show
29#
發(fā)表于 2025-3-26 15:01:08 | 只看該作者
30#
發(fā)表于 2025-3-26 20:32:58 | 只看該作者
Cerebral Parenchymal Arteriovenous Malformation (AVM)hymal AVM. The target volume of 3.1?cc received a marginal dose of 25.6 Gy normalized to 80% isodose line. Serial post-SRS follow-up MRIs showed progressive reduction in the size of AVM nidus, coupled with perinidal high signal in T2 and FLAIR studies, denoting vasogenic edema. At 24?months post-SRS
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-25 17:32
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
色达县| 交城县| 乐都县| 庆城县| 河北区| 宿迁市| 麻阳| 滨海县| 石城县| 黄大仙区| 红原县| 鹿泉市| 卢龙县| 土默特左旗| 梅州市| 潜江市| 双鸭山市| 黔东| 社旗县| 沁源县| 凌云县| 桦川县| 阆中市| 鸡东县| 琼结县| 巴彦县| 隆安县| 海城市| 冷水江市| 曲周县| 土默特右旗| 修水县| 东源县| 洪江市| 交城县| 娱乐| 宁安市| 清徐县| 河东区| 房山区| 祁连县|